Journal of Agricultural and Environmental Ethics

, Volume 27, Issue 6, pp 967–989 | Cite as

Risk Assessment of Genetically Modified Food and Neoliberalism: An Argument for Democratizing the Regulatory Review Protocol of the Food and Drug Administration

Articles

Abstract

The primary responsibility of the US Food and Drug Administration (FDA) is to protect public health by ensuring the safety of the food supply. To that end, it sometimes conducts risk assessments of novel food products, such as genetically modified (GM) food. The FDA describes its regulatory review of GM food (of both the plant and the animal variety) as a purely scientific activity, untainted by any normative considerations. This paper provides evidence that the regulatory agency is not justified in making that claim. It is argued that the FDA’s policy stance on GM food is shaped by neoliberal considerations. The agency’s review of a genetically engineered animal, the AquAdvantage salmon, is used as a case study to track the influence of neoliberalism on its regulatory review protocol. After that, an epistemic argument justifying public engagement in the risk assessment of new GM food is outlined. It is because risk evaluations involve normative judgments, in a democracy, layperson representatives of informal epistemic communities that could be affected by a new GM food should have the opportunity to decide the ethical, political or other normative questions that arise during the regulatory review of that entity.

Keywords

Genetically modified (GM) food Genetically engineered (GE) animals Neoliberalism Democracy US Food and Drug Administration (FDA) GM salmon 

References

  1. Anderson, E. (2006). The epistemology of democracy. Episteme: A journal of social epistemology, 3(1–2), 8–22.CrossRefGoogle Scholar
  2. Aqua Bounty Technologies. (2010). Environmental assessment for AquAdvantage salmon. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/UCM224760.pdf. Accessed 12 July 2014.
  3. Bohman, J. (2004). Realizing deliberative democracy as a mode of inquiry: Pragmatism, social facts, and normative theory. Journal of speculative philosophy, 18(1), 23–43.CrossRefGoogle Scholar
  4. Cattani, D., de Liz Oliveira Cavalli, V. L., Heinz Rieg, C. E., Domingues, J. T., Dal-Cim, T., Tasca, C. I., et al. (2014). Mechanisms underlying the neurotoxicity induced by glyphosate-based herbicide in immature rat hippocampus: Involvement of glutamate excitotoxicity. Toxicology, 5(320), 34–45. doi:10.1016/j.tox.2014.03.001.CrossRefGoogle Scholar
  5. Council on Environmental Quality and Office of Science and Technology Policy (CEQ/OSTP). (2001). CEQ/OSTP assessment: Case studies of environmental regulation for biotechnology. http://www.ostp.gov/html/012201.html. Accessed 11 June 2014.
  6. Domhoff, G. W. (2013). Wealth, income, and power. http://www2.ucsc.edu/whorulesamerica/power/wealth.html. Accessed 11 June 2014.
  7. Dunsby, J. (2004). Measuring environmental health risks: The negotiation of a public right-to-know law. Science, Technology and Human Values, 29, 269–290.CrossRefGoogle Scholar
  8. Federal Register 13193. Executive Order 12291. 17 Feb 1981.Google Scholar
  9. Federal Register 10084. Volume 49. 31 December 1984.Google Scholar
  10. Federal Food, Drug, and Cosmetic Act. (FFDCA, 2004). 21 U.S.C. section, pp. 301–397.Google Scholar
  11. Food and Agriculture Organization (FAO) of the United Nations. (2008). The state of world fisheries and aquaculture. Electronic Publishing Policy and Support Branch Communication Division, FAO: Rome.Google Scholar
  12. FoodRisk.org. (2011). Biographies. http://foodrisk.org/irac/events/2003-09-30/bios/. Accessed 11 June 2014.
  13. Gilens, M., & Page, B. (2014). Testing theories of American politics: Elites, interest groups, and average citizens. Perspectives on Politics, forthcoming. http://www.princeton.edu/~mgilens/Gilens%20homepage%20materials/Gilens%20and%20Page/Gilens%20and%20Page%202014-Testing%20Theories%203-7-14.pdf. Accessed 8 June 2014.
  14. Goldburg, R. (2002). Testimony of Rebecca Goldburg, PhD, Environmental Defense, concerning marine aquaculture, before the US Commission on Ocean Policy. Boston, MA: Environmental Defense.Google Scholar
  15. Guehlstorf, N. P. (2004). The political theories of risk analysis (The international library of environmental, agricultural and food ethics). New York: Springer.CrossRefGoogle Scholar
  16. Guia, Y., Fana, X., Wanga, H., Wanga, G., & Chena, S. (2012). Glyphosate induced cell death through apoptotic and autophagic mechanisms. Neurotoxicology and Teratology, 34(3), 344–349.CrossRefGoogle Scholar
  17. Harvey, D. (2005). A brief history of neoliberalism. Oxford: Oxford University Press.Google Scholar
  18. Hempel, C. (1966). Philosophy of natural science. Englewood Cliffs NJ: Prentice-Hall.Google Scholar
  19. Hempel, C. (2001). Valuation and objectivity in science. In J. H. Fetzer (Ed.), The philosophy of Carl G. Hempel. Oxford: Oxford University Press.Google Scholar
  20. Hoffman, E. (2011). GE mosquito release “remains on indefinite hold”—But for how long? http://www.foe.org/news/blog/2012-05-ge-mosquito-release-remains-on-indefinite-hold. Accessed 11 June 2014.
  21. Intemann, K., & Melo-Martín, I. (2010). Social values and scientific evidence: The case of the HPV vaccines. Biology and Philosophy, 25(2), 203–213.CrossRefGoogle Scholar
  22. Jasanoff, S. (1991). Acceptable evidence in a pluralistic society. In D. G. Mayo & R. D. Hollander (Eds.), Acceptable evidence: Science and values in risk management (pp. 29–47). New York: Oxford UP.Google Scholar
  23. Jasanoff, S. (2003). A living legacy: the precautionary ideal in American law. In J. Tickner (Ed.), Precaution, environmental science, and preventive public policy (pp. 227–240). Washington, DC: Island Press.Google Scholar
  24. Jasanoff, S. (2005). Designs on nature: Science and democracy in Europe and the United States. Princeton, NJ: Princeton University Press.Google Scholar
  25. Jensen, K. (2006). Conflict over risks in food production: A challenge for democracy. Journal of Agricultural and Environmental Ethics, 19(3), 269–283.CrossRefGoogle Scholar
  26. Johnson, G. F. (2007). Discursive democracy in the transgenerational context and a precautionary turn in public reasoning. Contemporary Political Theory, 6(1), 67–68.CrossRefGoogle Scholar
  27. Jones, M. E. (1999). Politically corrected science: The early negotiation of U.S. agricultural biotechnology policy. (Dissertation).Google Scholar
  28. Knorr-Cetina, K. (1995). How superorganisms change: Consensus formation and the social ontology of high-energy physics experiments. Social Studies of Science, 25, 119–147.CrossRefGoogle Scholar
  29. Levidow, L., Murphy, J., & Carr, S. (2007). Recasting ‘‘substantial equivalence’’: Transatlantic governance of gm food. Science, Technology and Human Values, 32(1), 26–64.CrossRefGoogle Scholar
  30. Li, T. M. (2007). The will to improve: Governmentality, development, and the practice of politics. Durham, NC: Duke University Press Books.CrossRefGoogle Scholar
  31. Logar, N., & Pollack, L. K. (2005). Transgenic fish: Is a new policy framework necessary for a new technology? Environmental Science & Policy, 8, 17–27.CrossRefGoogle Scholar
  32. Longino, H. (1990). Science as social knowledge. Princeton University Press, NJ: Princeton University Press.Google Scholar
  33. Madsen, K. H., & Sandøe, P. (2001). Herbicide resistant sugar beets—What is the problem? Journal of Agricultural and Environmental Ethics, 14(2), 161–168.CrossRefGoogle Scholar
  34. Meghani, Z. (2009). The US’ Food and Drug Administration, normativity of risk assessment, GMOs, and American democracy. Journal of Agricultural and Environmental Ethics, 22(2), 125–139.CrossRefGoogle Scholar
  35. Meghani, Z., & de Melo-Martín, I. (2009). The U.S. Food and Drug Administration’s evaluation of the safety of animal clones: A failure to recognize the normativity of risk assessment projects. Bulletin of Science, Technology & Society, 29, 9–17.CrossRefGoogle Scholar
  36. Meghani, Z., & Kuzma, J. (2011). The “revolving door” between regulatory agencies and industry: A problem that requires reconceptualizing objectivity. Journal of Agricultural and Environmental Ethics, 24(6), 575–599.CrossRefGoogle Scholar
  37. Menozzi, D., Mora, C., & Merigo, A. (2012). Genetically modified salmon for dinner? Transgenic salmon marketing scenarios. AgBioForum,15(3), 276–293. http://www.agbioforum.org/v15n3/v15n3a04-menozzi.pdf. Accessed 8 June 2014.
  38. Millstone, E., Brunner, E., & Mayer, S. (1999). Beyond ‘substantial equivalence’. Nature, 401, 525–526.CrossRefGoogle Scholar
  39. Murphy-Lawless, J. (2004). The impact of BSE and FMD on ethics and democratic process. Journal of Agricultural and Environmental Ethics, 17(4–5), 385–403.CrossRefGoogle Scholar
  40. Myhr, A. I., & Traavik, T. (2003). Sustainable development and Norwegian genetic engineering regulations: Applications, impacts, and challenges. Journal of Agricultural and Environmental Ethics, 16(4), 317–335.CrossRefGoogle Scholar
  41. National Research Council (NRC). (1983). Risk assessment in the federal government. Washington, DC: National Academy Press.Google Scholar
  42. National Research Council (NRC). (2002). Animal biotechnology: Identifying science-based concerns. Washington, DC: National Research Council.Google Scholar
  43. Nelson, L. H. (1993). Epistemological Communities. In Linda Alcoff (Ed.), Feminist epistemologies. New York: Routledge.Google Scholar
  44. Nielson, K. (1984). Equality and liberty: A defense of radical egalitarianism. Allanheld: Rowman.Google Scholar
  45. Office of Science, Technology Policy (OSTP). (1986). Coordinated framework for regulation of biotechnology. Federal Register, 51, 23302–23393.Google Scholar
  46. Office of Science & Technology Policy, Executive Office of The President. (2001). Case study no. 1: Growth-enhanced salmon. Case Studies of Environmental Regulation for Biotechnology. http://www.whitehouse.gov/files/documents/ostp/Issues/ceq_ostp_study2.pdf. Accessed 11 June 2014.
  47. Peck, J., & Tickell, A. (2002). Neoliberalizing space. Antipode, 34(3), 380–404.CrossRefGoogle Scholar
  48. Pollack, A. (2010). Genetically altered salmon get closer to the table. NY Times. Business Day section, online edition. http://www.nytimes.com/2010/06/26/business/26salmon.html?pagewanted=all. Accessed 24 July 2014.
  49. President’s Council on Competitiveness. (1991). Report on national biotechnology policy. http://babel.hathitrust.org/cgi/pt?id=umn.31951003088116i;seq=5;view=1up;num=iii. Accessed 17 Mar 2013.
  50. Rabin, R. C. (2014). Labs are told to start including a neglected variable: Females. NY Times. http://www.nytimes.com/2014/05/15/health/nih-tells-researchers-to-end-sex-bias-in-early-studies.html?_r=1. Accessed 8 June 2014.
  51. Reagan, R. (1982). Message to the congress transmitting the annual economic report of the President. http://www.reagan.utexas.edu/archives/speeches/1982/21082a.htm. Accessed 11 June 2014.
  52. Rollin, B. (1995). The Frankenstein syndrome: Ethical and social issues in the genetic engineering of animals. New York: Cambridge University Press.CrossRefGoogle Scholar
  53. Rose, N. (1999). Powers of freedom: Reframing political thought. New York: Cambridge University Press.CrossRefGoogle Scholar
  54. Schrader-Frechette, K. (1991). Risk and rationality: Philosophical foundations for populist reforms. California: University of California Press.Google Scholar
  55. Sheingate, A. D. (2006). Promotion versus precaution: The evolution of biotechnology policy in the United States. British Journal of Political Science, 36(2), 243–268.CrossRefGoogle Scholar
  56. Sunstein, C. R. (2002). Risk and reason. Cambridge: Cambridge University Press.Google Scholar
  57. Tait, J. (2009). Upstream engagement and the governance of science: The shadow of the genetically modified crops experience in Europe. EMBO Reports, 10(S1), S18–S22.CrossRefGoogle Scholar
  58. Union of Concerned Scientists (UCS). (2001). Update on genetically engineered fish. www.ucsusa.org/food/upd-gefish.html. Accessed 12 Feb 2014.
  59. Unknown. (2013). AquaBounty cleared to produce salmon eggs in Canada for commercial purposes (Press release). Wall Street Journal. http://online.wsj.com/article/PR-CO-20131125-903183.html. Accessed 14 June 2014.
  60. US EPA. (unknown). Environmental assessments & environmental impact statements. http://www.epa.gov/reg3esd1/nepa/eis.htm. Accessed 11 June 2014.
  61. US FDA. (1999). Genetically engineered foods: Statement of James H. Maryanski before the Subcommittee on Basic Research House Committee on Science. October 19. http://www.fda.gov/newsevents/testimony/ucm115032.htm. Accessed 11 June 2014.
  62. US FDA. (2008). FDA’s response to public comment on the animal cloning risk assessment, risk management plan, and guidance for industry (Docket No. 2003 N-0573). Available at http://www.fda.gov/AnimalVeterinary/SafetyHealth/AnimalCloning/ucm055491.htm. Accessed 11 June 2014.
  63. US FDA (2009). Guidance for industry regulation of genetically engineered animals containing heritable recombinant DNA constructs final guidance. http://www.fda.gov/downloads/%20AnimalVeterinary/GuidanceComplianceEnforcement/%20%20GuidanceforIndustry/UCM113903.pdf. Accessed 11 June 2014.
  64. US FDA. (2010b). Transcript for the September 20, 2010 Veterinary Medicine Advisory Committee Meeting. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/UCM230471.pdf. Accessed 11 June 2014.
  65. US FDA. (unknown). About FDA: What we do. http://www.fda.gov/AboutFDA/WhatWeDo/default.htm. Accessed 11 June 2014.
  66. US FDA. (2012c). Briefing packet for AquAdvantage salmon Veterinary Medicine Advisory Committee. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/UCM224762.pdf. Accessed 11 June 2014.
  67. US FDA. (unknown). Advisory committees: Veterinary Medicine Advisory Committee. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/default.htm. Accessed 14 June 2014.
  68. US FDA. (2014). Importation of Active Pharmaceutical Ingredients (APIs) Requirements FD&C Act 201(g) & (p) [21 USC 321(g) & (p)]: Definitions; generally (Tab B). http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm118000.pdf. Accessed 11 June 2014.
  69. US Congress, House of Representatives, Committee on Science and Technology. (1982). US science and technology under budget stress. US Government Printing Office, Washington, DC. December 10, 1981 and February 2, 3, 4, 1982. Hearings. 97/118.Google Scholar
  70. US DHHS, USDA, US EPA. (2011). Memorandum of understanding among Department of Health and Human Services, FDA, and Department of Agriculture, Animal and Plant Health Inspection Service, Biotechnology Regulation Services and EPA, Office of Chemical Safety and Pollution Prevention, Office of Pesticide Programs. 10-2000-0058-MU 225-11-0001. http://www.epa.gov/oppbppd1/biopesticides/pips/biotech-mou.pdf. Accessed 11 June 2014.
  71. USDA. (unknown). Dietary Guidance: MyPlate and Historical Food Pyramid Resources: Special Audience MyPlate Resources. http://fnic.nal.usda.gov/dietary-guidance/myplate-and-historical-food-pyramid-resources/special-audience-myplate-resources. Accessed 24 July 2014.
  72. World Health Organization. (2008). Guideline for the conduct of food safety assessment of foods derived from recombinant-DNA animals CAC/GL 68-2008. http://www.who.int/foodsafety/biotech/codex_taskforce/en/. Accessed 11 June 2014.
  73. Wynne, B. (1989). Sheep farming after Chernobyl: a case study in communicating scientific information. Environment, 31(2), 11–39.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Philosophy DepartmentUniversity of Rhode IslandKingstonUSA

Personalised recommendations